glp-1 suicide Postmarket safety profile of suicide/self-injury for receptor agonist: a real-world pharmacovigilance analysis Exploration of the potential association
Description
A significant reduction in alcohol intake was observed at follow-up compared with baseline, including among adults who were considered high alcohol consumers and drank more than 11 U alcohol per week at the start of the study
Karakasis et al
doi: 10.3389/fpubh.2022.996179 [DOI] [PMC free article] [PubMed] [Google Scholar] 25.Smits MM, Van Raalte DH (2021) Safety of semaglutide
Its used for type 2 diabetes and has a recently approved cardiovascular label extension, and one oral semaglutide product in development for obesity and cardiovascular risk reduction
Semaglutide represents the most widely discussed GLP-1 receptor agonist for weight management
